AlphaMadera's AlphaVal page computes Anheuser-Busch InBev SA/NV's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag BUD as undervalued, fairly valued, or overvalued.

What is Anheuser-Busch InBev SA/NV's fair value?

Fair value for BUD is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value BUD?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from BUD's most recent reported fundamentals.

BUD - Anheuser-Busch InBev SA/NV

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $89.83 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Fair Value Moderate

Trading 18.2% below fair value

Current Price $83.20

Bear Case $87.19 4.8% upside ($87.19 - $83.20) / $83.20 = 4.8% $5.09 × 18x P/E

Fair Value $101.72 22.3% upside ($101.72 - $83.20) / $83.20 = 22.3% $5.09 × 21x P/E

Bull Case $116.25 39.7% upside ($116.25 - $83.20) / $83.20 = 39.7% $5.09 × 24x P/E

Adjust Assumptions

P/E Multiple

21.0x

Adjusted EPS

5.09$

Key Value Driver

Normalized P/E multiple (21x base case)

Implied Market Multiple 16.4x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $89.83 from 45 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $101.72 per share.

Warnings

⚠ The company's reported profits differ from official accounting profits by 47%. Check what costs are being left out of the adjusted number.

⚠ The company pays out 97% of its profits as dividends. That leaves little cushion — the dividend could be cut if business slows down.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples